AstraZeneca PLC (AZN)
AZN chart
Everything the smart money is doing in AZN
This is the AZN details page members see in the GTA Terminal. Previews below are blurred samples; start a free trial to see the live data.
Option Flows for AZN
Every unusual options bet in AZN: size, strikes, expirations and which side the money is on.
Start 14-day free trialAlready a member? Open in the Terminal →Insiders & Congress for AZN
6 insider filings on record for AZN. See who bought and sold, how much, and when.
Start 14-day free trialAlready a member? Open in the Terminal →Institutions for AZN
Which hedge funds and institutions are buying and selling AZN.
Start 14-day free trialAlready a member? Open in the Terminal →Short interest for AZN
Short interest data for AZN through 2026-09-30: percent of shares short, days to cover and the squeeze score.
Start 14-day free trialAlready a member? Open in the Terminal →Financials & earnings for AZN
Eight quarters of revenue, margins and EPS for AZN, every earnings beat and miss, and conference-call notes.
Start 14-day free trialAlready a member? Open in the Terminal →GTA AI for AZN
Ask GTA AI for a trade idea on AZN: bias, entry, stop and target, built from all of the data above.
Start 14-day free trialAlready a member? Open in the Terminal →Sample previews with placeholder values. Then $99/month. Cancel anytime.
Technical summary daily
| Moving average | Simple | Exponential | Signal |
|---|---|---|---|
| MA5 | 158.56 | 158.04 | Sell |
| MA10 | 158.40 | 159.10 | Sell |
| MA20 | 162.02 | 160.55 | Sell |
| MA50 | 161.83 | 163.64 | Sell |
| MA100 | 170.20 | 168.86 | Sell |
| MA200 | 181.26 | 175.49 | Sell |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 33.81 | Sell |
| MACD(12,26) | -1.68 | Sell |
| Stochastic(14) | 12.35 | Oversold |
| ROC(12) | -6.12 | Sell |
Classic pivot points from the last full session. Technical signals are mechanical readings, not recommendations.
AstraZeneca PLC news
European Indexes Largely Rise, Though AI Stocks FallThe Wall Street Journal · 12 hr agoHow Investors May Respond To HUTCHMED (China) (AIM:HCM) US NDA For ORPATHYS–TAGRISSO Lung Cancer ComboSimply Wall St. · 16 hr agoAstraZeneca HPP Drug Shows Gains Despite Missing Key Phase III EndpointMarketBeat · Oct 12, 2026AstraZeneca's efzimfotase alfa adult data point to $4.4bn peak sales potential, says CitiProactive · Oct 12, 2026Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug dataBioPharma Dive · Oct 12, 2026AstraZeneca pins bone disease drug’s Phase III failure on high placebo responseClinical Trials Arena · Oct 12, 20263 British AI Healthcare Stocks With At Least 4% Revenue GrowthSimply Wall St. · Oct 11, 2026AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie UpSimply Wall St. · Oct 10, 2026How do you see AstraZeneca PLC today?
Results show once a few readers have voted today.
Historical data daily, last 20 sessions
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | 156.38 | 160.76 | 160.83 | 156.17 | 1.87M | -1.23% |
| Oct 12, 2026 | 158.33 | 159.44 | 159.44 | 157.60 | 2.86M | -0.55% |
| Oct 09, 2026 | 159.20 | 159.45 | 160.07 | 158.53 | 2.12M | +0.26% |
| Oct 08, 2026 | 158.78 | 159.80 | 160.05 | 156.72 | 3.49M | -0.84% |
| Oct 07, 2026 | 160.12 | 159.12 | 161.29 | 158.53 | 2.46M | +0.95% |
| Oct 06, 2026 | 158.61 | 159.80 | 159.96 | 156.26 | 2.05M | +1.33% |
| Oct 05, 2026 | 156.53 | 156.76 | 157.20 | 154.81 | 2.26M | -0.24% |
| Oct 02, 2026 | 156.90 | 158.46 | 158.80 | 156.41 | 3.04M | -0.51% |
| Oct 01, 2026 | 157.70 | 160.77 | 161.33 | 157.54 | 3.38M | -2.33% |
| Sep 30, 2026 | 161.47 | 164.47 | 164.48 | 161.46 | 2.23M | -1.67% |
| Sep 29, 2026 | 164.21 | 165.09 | 166.47 | 163.24 | 3.37M | -1.17% |
| Sep 28, 2026 | 166.15 | 165.69 | 167.52 | 165.39 | 1.73M | -0.26% |
| Sep 25, 2026 | 166.58 | 166.16 | 166.81 | 164.60 | 2.07M | +1.23% |
| Sep 24, 2026 | 164.56 | 162.91 | 166.25 | 162.91 | 3.19M | +0.75% |
| Sep 23, 2026 | 163.33 | 166.58 | 167.59 | 163.33 | 2.36M | -2.99% |
| Sep 22, 2026 | 168.37 | 167.84 | 169.35 | 166.74 | 2.31M | +0.16% |
| Sep 21, 2026 | 168.10 | 168.45 | 169.00 | 167.11 | 2.94M | +1.22% |
| Sep 18, 2026 | 166.08 | 167.15 | 167.83 | 165.54 | 3.06M | -0.04% |
| Sep 17, 2026 | 166.14 | 164.59 | 166.29 | 164.30 | 3.81M | +2.00% |
| Sep 16, 2026 | 162.89 | 164.21 | 165.42 | 162.02 | 3.86M | +0.64% |
Full history, intraday charts and downloads are in the GTA Terminal.
About AstraZeneca PLC
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide.
FAQ
What is the price of AstraZeneca PLC today?
AstraZeneca PLC (AZN) last traded at 156.38, down 1.23% on the day.
What is the 52-week range of AZN?
Over the past 52 weeks AZN has traded between 153.41 and 212.71.
Is AZN a buy or a sell?
Daily technical indicators currently read Strong Sell (0 buy vs 9 sell signals). That is a mechanical reading, not advice.
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.